메뉴 건너뛰기




Volumn 3, Issue 1, 1998, Pages 38-58

HIV vaccine research and human rights: Examples from three countries planning efficacy trials

Author keywords

[No Author keywords available]

Indexed keywords

HEALTHCARE; HIV; HUMAN RIGHTS; VACCINE RESEARCH;

EID: 0031855054     PISSN: 10790969     EISSN: None     Source Type: Journal    
DOI: 10.2307/4065284     Document Type: Article
Times cited : (4)

References (4)
  • 1
    • 11544252969 scopus 로고    scopus 로고
    • In 1983, then Secretary of the U.S. Department of Health and Human Services, Margaret Heckler, predicted development of a vaccine for AIDS within a few years
    • In 1983, then Secretary of the U.S. Department of Health and Human Services, Margaret Heckler, predicted development of a vaccine for AIDS within a few years.
  • 2
    • 11544265082 scopus 로고    scopus 로고
    • Phase I trials are designed to test the safety of experimental products. Phase II trials typically test safety and immunogenicity. Phase III trials may involve several thousand participants and test safety and efficacy
    • Phase I trials are designed to test the safety of experimental products. Phase II trials typically test safety and immunogenicity. Phase III trials may involve several thousand participants and test safety and efficacy.
  • 3
    • 84942949575 scopus 로고
    • Ethical, Behavioral, and Social Aspects of HIV Vaccine Trials in Developing Countries
    • P. Lurie, M. Bishaw, M.A. Chesney, et al., "Ethical, Behavioral, and Social Aspects of HIV Vaccine Trials in Developing Countries," Journal of the American Medical Association 271(4) (1994):298.
    • (1994) Journal of the American Medical Association , vol.271 , Issue.4 , pp. 298
    • Lurie, P.1    Bishaw, M.2    Chesney, M.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.